Beacon Pointe Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Beacon Pointe Advisors, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $52.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$52.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 19,460 | $15.0M |
| GILDGILEAD SCIENCES, INC. | 89,731 | $12.5M |
| SNYSanofi | 194,941 | $9.4M |
| INCYIncyte Corp. | 73,301 | $6.9M |
| NUVBNuvation Bio Inc. | 643,734 | $2.8M |
| SMMTSummit Therapeutics Inc. | 94,394 | $1.8M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 26,410 | $1.5M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,157 | $383K |
| VKTXViking Therapeutics, Inc. | 9,767 | $318K |
| IBRXImmunityBio, Inc. | 40,227 | $309K |
| AQSTAquestive Therapeutics, Inc. | 60,500 | $251K |
| ARGXARGENX SE | 334 | $244K |
| EXELEXELIXIS, INC. | 5,626 | $241K |
| MRNAModerna, Inc. | 4,186 | $213K |
| LGVNLongeveron Inc. | 100,000 | $104K |
| AVXLANAVEX LIFE SCIENCES CORP. | 23,000 | $71K |
| BTAIBioXcel Therapeutics, Inc. | 18,877 | $25K |
| ALXOALX ONCOLOGY HOLDINGS INC | 12,500 | $25K |
| HUMAHumacyte Inc. | 36,000 | $22K |
| IOBTQIO Biotech, Inc. | 42,600 | $3K |
| CUECue Biopharma, Inc. | 10,000 | $2K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.